menu search

Astrazeneca's experimental asthma gets an orphan drug designation for another disease

U.S.-listed shares of AstraZeneca AZN, +0.85% gained 0.3% in premarket trading on Friday after the company said an experimental asthma drug it is deve...

October 8, 2021, 8:08 am

Astrazeneca's experimental asthma gets an orphan drug designation for another disease

U.S.-listed shares of AstraZeneca AZN, +0.85% gained 0.3% in premarket trading on Friday after the company said an experimental asthma drug it is deve...

October 8, 2021, 8:08 am

Astrazeneca's experimental asthma gets an orphan drug designation for another disease

U.S.-listed shares of AstraZeneca AZN, +0.85% gained 0.3% in premarket trading on Friday after the company said an experimental asthma drug it is deve...

October 8, 2021, 8:08 am

Amgen, neumora collaborate on precision therapies for brain diseases

Amgen Inc (NASDAQ: AMGN) and Neumora Therapeutics Inc have announced a strategic collaboration to advance neuroscience discovery, development, and ...

October 7, 2021, 7:27 am

Amgen, neumora collaborate on precision therapies for brain diseases

Amgen Inc (NASDAQ: AMGN) and Neumora Therapeutics Inc have announced a strategic collaboration to advance neuroscience discovery, development, and ...

October 7, 2021, 7:27 am

Amgen, neumora collaborate on precision therapies for brain diseases

Amgen Inc (NASDAQ: AMGN) and Neumora Therapeutics Inc have announced a strategic collaboration to advance neuroscience discovery, development, and ...

October 7, 2021, 7:27 am


Search within

Pages Search Results: